“Bullish on Ind-Swift Laboratories, advising investors to buy, hold, and accumulate the stock. He expects an upside of 215-230, citing a confirmed 'rounding bottom' breakout on the weekly chart at 187 with massive volumes, sustained uptrend above key moving averages, and favorable RSI and Bollinger Band buy signals.”

Rajesh Palviya’s track record: 10 graded calls · 95% CI 2–40%